| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |